Data From Final Cohort Of Patients In Patrys Limited (PAB.AX) Multiple Myeloma Clinical Trial
12/2/2013 11:25:57 AM
MELBOURNE, Australia--(BUSINESS WIRE)--Patrys Limited (ASX:PAB), a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma (MM) will be presented at the 55th American Society of Hematology (ASH) Annual Meeting in New Orleans, LA on 7- 10 December 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by